State Street Corporation 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 07:27 am Sale | 2024-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | STATE STREET CORP STT | 8,328,817 5.200% | -1,591,048 (-16.04%) | Filing |
| 2024-10-16 10:04 am Sale | 2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | STATE STREET CORP STT | 9,919,865 6.200% | -1,612,223 (-13.98%) | Filing |
| 2024-01-25 09:21 am Purchase | 2023-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | STATE STREET CORP STT | 11,532,088 7.390% | 352,510 (+3.15%) | Filing |
| 2023-02-02 12:34 pm Purchase | 2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | STATE STREET CORP STT | 11,179,578 7.290% | 11,179,578 (New Position) | Filing |